CRYO-ROP PARTICIPATING CENTER

这是一个申请成为合作中心之一， 早产儿视网膜病变的冷冻治疗研究。 CRYO-ROP研究 主要包括两个研究部分：（1）临床试验， 冷冻治疗在降低老年人致盲率中的安全性和有效性 重度、高危、ROP;（2）自然史研究（雅阁 与ROP的国际分类）早产儿视网膜病变 极低出生体重儿（小于1251 g）。 在这份提案中，我们记录了我们眼科医生团队的能力， 和产科医生每年招募120名极低出生体重婴儿 在自然史研究中存活了至少28天的人。 我们 预计这些婴儿中约有12人将患上视网膜病， 早产严重到有资格参加 临床试验 CRYO-ROP研究由Earl A.帕尔默医学博士，在俄勒冈州健康中心 科学大学。 协调中心由罗伯特J。 哈代博士，德克萨斯大学休斯顿健康科学中心的研究人员。

This is an application to become one of the cooperating centers in the Cryotherapy for Retinopathy of Prematurity Study. The CRYO-ROP Study consists of essentially two research components: (1) a clinical trial of the safety and efficacy of cryotherapy in reducing blindness in eyes of severe, high risk, ROP; and (2) a study of the natural history (in accord with the International Classification of ROP) of retinopathy of prematurity in very low birth weight infants (less than 1251g). In this proposal, we document the ability of our group of ophthalmologists and neonatologists to enroll, each year, 120 very low birth weight infants who have survived for at least 28 days in the natural history study. We anticipate that approximately 12 of these infants will develop retinopathy of prematurity severe enough to become eligible for enrollment in the clinical trial. The CRYO-ROP Study is chaired by Earl A. Palmer, M.D., at the Oregon Health Sciences University. The Coordinating Center is directed by Robert J. Hardy, Ph.D., at the University of Texas Health Sciences Center, Houston.